April 27, 2020
-AstraZeneca ads to Lokelma use in hyperkalemia
AstraZeneca has updated use of Lokelma based on data from Phase IIIb DIALIZE trial.
Pharmaceuticals, Biotechnology and Life Sciences
AstraZeneca has updated use of Lokelma based on data from Phase IIIb DIALIZE trial.
The US Food and Drug Administration (FDA) has approved Lokelma (sodium zirconium cyclosilicate), formerly ZS-9, for the treatment of adults…